Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01 NS105432)
Parkinson’s Disease Foundation (PF-FBS-1768)
- License Information
-
More Information
Article History
Received: 9 December 2022
Accepted: 11 July 2023
First Online: 4 August 2023
Declarations
:
: All animal procedures were conducted in accordance with the guidelines set forth by the Institutional Animal Care and Use Committee (IACUC) at Van Andel Institute, and study protocols were reviewed and approved prior to performing the experimental procedures described.
: All authors read and approved the final manuscript.
: The authors declare they have no financial competing interests. ET is currently an employee of AC Immune SA.
